Macrophages in islet destruction in autoimmune diabetes mellitus

Immunobiology

Volumn 195, Issue 4-5, 1996, Pages 601-613

  Burkart, Volker ^a,b   Kolb, Hubert ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNITY; CONFERENCE PAPER; DIABETES MELLITUS; GENETIC PREDISPOSITION; GLUCOSURIA; HYPERGLYCEMIA; HYPOINSULINEMIA; INSULITIS; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MONOCYTE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION;

EID: 0029825447     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(96)80025-8     Document Type: Conference Paper

References (49)

1. CRISA, L., J. P. MORDES, and A. A. ROSSINI. 1992. Autoimmune diabetes in the BB rat. Diabetes Metab. Rev. 8: 4.
2. SCOTT, J. 1990. The spontaneously diabetic BB rat: sites of the defects leading to autoimmunity and diabetes mellitus. A review. Curr. Topics Microbiol. Immunol. 156: 1.
3. MARLISS, E. B., A. F. NAKHOODA, P. POUSSIER, and A. A. F. SIMA. 1982. The diabetic syndrome of the «BB»Wistar rat: possible relevance to type 1 (insulin-dependent) diabetes in man. Diabetologia 22: 225.
4. MORDES, J. P., J. DESEMONE, and A. A. ROSSINI. 1987. The BB rat. Diabetes Metab. Rev. 3: 725.
5. COLLE, E., A. FUKS, P. POUSSIER, P. EDOUARD, and R. D. GUTTMANN. 1992. Polygenic nature of spontaneous diabetes in the rat. Permissive MHC haplotype and presence of the lymphopenic trait of the BB rat are not sufficient to produce susceptibility. Diabetes 41: 1617.
6. ONO, S. J., A. FUKS, R. D. GUTTMAN, and E. COLLE. 1989. Susceptibility and resistance genes to insulin-dependent diabetes mellitus in the BB rat. Exp. Clin. Immunogenet. 6: 169.
7. DYRBERG, T., A. F. NAKHOODA, S. BAEKKESKOV, A. LERNMARK, P. POUSSIER, and E. B. MARLISS. 1982. Islet cell surface antibodies and lymphocyte antibodies in the spontaneously diabetic BB Wistar rat. Diabetes 31: 278.
8. ZIEGLER, M., M. SCHLOSSER, J. HAMANN, P. VIEREGGE, F. LUHDER, I. KLOTING, and B. ZIEGLER. 1994. Autoantibodies to glutamate decarboxylase detected in diabetes-prone BB/OK rats do not distinguish onset of diabetes. Exp. Clin. Endocrinol. 102: 98.
9. ZIEGLER, B., S. WITT, K. D. KOHNERT, M. SCHLOSSER, P. AUGSTEIN, D. MICHAELIS, I. KLOTING, and M. ZIEGLER. 1993. Characterization of monoclonal islet cell reactive autoantibodies from the diabetic biobreeding (BB/OK) rat. Acta Diabetol. 30: 201.
10. KOLB, H., U. KIESEL, K. FLOHR, B. GREULICH, G. FREYTAG, and V. KOLB-BACHOFEN. 1984. Cell mediated immunity to islet cells: Lessons from animal studies. Behring Inst. Mitt. 75: 33.
11. HANENBERG, H., V. KOLB-BACHOFEN, G. KANTWERK-FUNKE, and H. KOLB. 1989. Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of prediabetic BB rats. Diabetologia 32: 126.
12. KOLB-BACHOFEN, V., S. EPSTEIN, U. KIESEL, and H. KOLB. 1988. Low-dose streptozocin-induced diabetes in mice. Electron microscopy reveals single-cell insulitis before diabetes onset. Diabetes 37: 21.
13. LEE, K.-U., K. AMANO, and J.-W. YOON. 1988. Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 37: 989.
14. IHM, S. H., K.-U. LEE, B. D. RHEE, and H. K. MIN. 1990. Initial role of macrophage in the development of anti-β-cell cellular autoimmunity in multiple low-dose streptozotocin-induced diabetes in mice. Diab. Res. Clin. Pract. 10: 123.
15. OSCHILEWSKI, U., U. KIESEL, and H. KOLB. 1985. Administration of silica prevents diabetes in BB rats. Diabetes 34: 197.
16. LEE, K. U., C. Y. PAK, K. AMANO, and J.-W. YOON. 1988. Prevention of lymphocytic thyroiditis and insulitis in diabetes prone BB rats by the depletion of macrophages. Diabetologia 31: 400.
17. CHARLTON, B., A. BACELJ, and T. E. MANDEL. 1988. Administration of silica particles or anti-Lyt2 antibodies prevents β-cell destruction in NOD mice given cyclophosphamide. Diabetes 37: 930.
18. OSCHILEWSKI, M., E. SCHWAB, U. KIESEL, U. OPITZ, K. STÜNKEL, V. KOLB-BACHOFEN, and H. KOLB. 1986. Administration of silica or monoclonal antibody to Thy-1 prevents low-dose streptozotocin-induced diabetes in mice. Immunol. Lett. 12: 289.
19. APPELS, B., V. BURKART, G. KANTWERK-FUNKE, J. FUNDA, V. KOLB-BACHOFEN, and H. KOLB. 1989. Spontaneous cytotoxicity of macrophages against pancreatic islet cells. J. Immunol. 142: 3803.
20. KRÖNCKE, K.-D., V. KOLB-BACHOFEN, B. BERSCHICK, V. BURKART, and H. KOLB. 1991. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem. Biophys. Res. Commun. 175: 752.
21. WIEGAND, F., K.-D. KRÖNCKE, and V. KOLB-BACHOFEN. 1993. Macrophage generated nitric oxide as cytotoxic factor in destruction of alginate-encapsulated islets. Protection by arginine analogs and/or coencapsulated erythrocytes. Transplantation 56: 1206.
22. TSUJIMOTO, M., Y. K. YIP, and J. VILCEK. 1985. Tumor necrosis factor: Specific binding and internalization in sensitive and resistant cells. Proc. Natl. Acad. Sci. USA 82: 7626.
23. MONCADA, S., R. M. J. PALMER, and E. A. HIGGS. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109.
24. MONCADA, S., and E. A. HIGGS. 1991. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 21: 361.
25. MONCADA, S., and A. HIGGS. 1993. The L-arginine-nitric oxide pathway. New Engl. J. Med. 329: 2002.
26. KRÖNCKE, K.-D., M.-L. RODRIGUEZ, H. KOLB, and V. KOLB-BACHOFEN. 1992. Cytotoxicity of activated rat macrophages against syngeneic islet cells is arginine-dependent, correlates with citrulline and nitrite concentrations and is identical to lysis by the nitric oxide donor nitroprusside. Diabetologia 36: 17.
27. SATOH, M. S., and T. LINDAHL. 1992. Role of poly(ADP-ribose) formation in DNA repair. Nature 356: 356.
28. UCHIGATA, Y., H. YAMAMOTO, A. KAWAMURA, and H. OKAMOTO. 1982. Protection by superoxide dismutase, catalase, and poly(ADP-ribose)synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J. Biol. Chem. 257: 6084.
29. KALLMANN, B., V. BURKART, K.-D. KRÖNCKE, V. KOLB-BACHOFEN, and H. KOLB. 1992. Toxicity of chemically generated nitric oxide towards pancreatic islet cells can be prevented by nicotinamide. Life Sci. 51: 671.
30. FEHSEL, K., V. KOLB-BACHOFEN, and H. KOLB. 1991. Analysis of TNF-alpha-induced DNA strand breaks at the single cell level. Am. J. Pathol. 139: 251.
31. FEHSEL, K., A. JALOWY, Q. SUN, V. BURKART, B. HARTMANN, and H. KOLB. 1993. Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes 42: 496.
32. HELLER, B., A. BÜRKLE, J. RADONS, E. FENGLER, A. JALOWY, M. MÜLLER, V. BURKART, and H. KOLB. 1994. Analysis of oxygen radical toxicity in pancreatic islets at the single cell level. Biol. Chem. Hoppe-Seyler 375: 597.
33. HELLER, B., Z.-Q. WANG, E. F. WAGNER, J. RADONS, A. BÜRKLE, K. FEHSEL, V. BURKART, and H. KOLB. 1995. Inactivation of the poly(ADP-ribose)polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J. Biol. Chem. 270: 11176.
34. + depletion. Biochem. Biophys. Res. Commun. 199: 1270.
35. WU, G. 1995. Nitric oxide synthesis and the effect of aminoguanidine and NG-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB-rat. Diabetes 44: 360.
36. LINDSAY, R. M., W. SMITH, S. P. ROSSITER, M. A. MCINTYRE, B. C. WILLIAMS, and J. D. BAIRD. 1995. Nw-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E rats. Diabetes 44: 365.
37. KOLB, H., U. KIESEL, K.-D. KRÖNCKE, and V. KOLB-BACHOFEN. 1991. Suppression of low dose streptozotocin-induced diabetes in mice by administration of a nitric oxide synthase inhibitor. Life Sci. 25: PL-213.
38. PAPACCIO, G., V. ESPOSITO, M. V. G. LATRONICO, and F. A. PISANTI. 1995. Administration of a nitric oxide synthase inhibitor does not suppress low-dose streptozotocin-induced diabetes in mice. Int. J. Pancreatol. 17: 63.
39. LUKIC, M. L., S. STOSIC-GRUJICIC, N. OSTOJIC, W. L. CHAN, and F. Y. LIEW. 1991. Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice. Biochem. Biophys. Res. Commun. 178: 913.
40. HOLSTAD, M., and S. SANDLER. 1993. Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycemia induced by multiple low dose streptozotocin injections in mice. Autoimmunity 15: 311.
41. BOWMAN, M., O. SIMELL, Z. LOOK, R. LUCHETTA, and M. ATKINSON. 1994. Pharmacokinetik and therapeutic analysis of aminoguanidine (AG) in non-obese diabetic (NOD) mice. Diabetes 43 (Suppl. 1): 733A.
42. CORBETT, J. A., A. MIKHAEL, J. SHIMIZU, K. FREDERICK, T. P. MISKO, M. L. MCDANIEL, O. KANAGAWA, and E. R. UNANUE. 1993. Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc. Natl. Acad. Sci. USA 90: 8992.
43. ISCHIROPOULOS, H., L. ZHU, and J. S. BECKMAN. 1992. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298: 446.
44. 2, and HOCl. Arch. Biochem. Biophys. 304: 189.
45. HARBRECHT, B. G., T. R. BILLIAR, J. STADLER, A. J. DEMETRIS, J. OCHOA, R. D. CURRAN, and R. L. SIMMONS. 1992. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical mediated hepatic injury. J. Leukoc. Biol. 52: 390.
46. LEE, K.-U. 1994. Nitric oxide produced by macrophages mediates suppression of ConA-induced proliferative responses of splenic leukocytes in the diabetes-prone BB rat. Diabetes 43: 1218.
47. WEI, X.-Q., I. G. CHARLES, A. SMITH, J. URE, G.-J. FENG, F.-P. HUANG, D. XZ, W. MÜLLER, S. MONCADA, and F. Y. LIEW. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408.
48. ROTHE, H., V. BURKART, A. FAUST, and H. KOLB. 1996. Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice. Diabetologia (in press).
49. WANG, Z.-Q., B. AUER, L. STINGL, H. BERGHAMMER, D. HAIDACHER, M. SCHWAIGER, and E. WAGNER. 1995. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev. 9: 509.